Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis
AS Albanna, BM Smith, D Cowan… - European Respiratory …, 2013 - Eur Respiratory Soc
Fixed-dose combination (FDC) formulations are currently recommended for the treatment of
active tuberculosis (TB). We have conducted a systematic review to evaluate the risk of …
active tuberculosis (TB). We have conducted a systematic review to evaluate the risk of …
Reduced Transmissibility of East African Indian Strains of Mycobacterium tuberculosis
AS Albanna, MB Reed, KV Kotar, A Fallow… - PloS one, 2011 - journals.plos.org
Background Mycobacterium tuberculosis (MTB) has been classified into 4 main lineages.
Some reports have associated certain lineages with particular clinical phenotypes, but there is …
Some reports have associated certain lineages with particular clinical phenotypes, but there is …
Outcome of pediatric acute kidney injury: a multicenter prospective cohort study
…, SA Al Rezgan, S El Desoky, AS Albanna - Pediatric …, 2018 - Springer
Background Acute kidney injury (AKI) is a common problem encountered in critically ill children
with an increasing incidence and evolving epidemiology. AKI carries a serious morbidity …
with an increasing incidence and evolving epidemiology. AKI carries a serious morbidity …
Factors that influence mortality in critically ill patients with SARS-CoV-2 infection: a multicenter study in the Kingdom of Saudi Arabia
…, HM Nur, OF Kashari, FA Qari, AS Albanna… - Healthcare, 2021 - mdpi.com
Background: SARS-CoV-2 infection has a high mortality rate and continues to be a global
threat, which warrants the identification of all mortality risk factors in critically ill patients. …
threat, which warrants the identification of all mortality risk factors in critically ill patients. …
Acute kidney injury in children with COVID-19: a retrospective study
JA Kari, MA Shalaby, AS Albanna, TS Alahmadi… - BMC nephrology, 2021 - Springer
Background Acute kidney injury (AKI) is a complication of coronavirus disease 2019 (COVID-19).
The reported incidence of AKI, however, varies among studies. We aimed to evaluate …
The reported incidence of AKI, however, varies among studies. We aimed to evaluate …
[HTML][HTML] The clinical course of COVID-19 pneumonia in a 19-year-old man on intravenous immunoglobulin replacement therapy for X-linked agammaglobulinemia
…, AK Alsuraihi, H Binyahib, AS Albanna - The American Journal …, 2021 - ncbi.nlm.nih.gov
… The patient’s condition improved 3 days after admission. After receiving his regular IVIG
dose, he was transferred to an isolation facility designated for stable COVID-19 patients. The …
dose, he was transferred to an isolation facility designated for stable COVID-19 patients. The …
[HTML][HTML] Childhood nephrolithiasis and nephrocalcinosis caused by metabolic diseases and renal tubulopathy: A retrospective study from 2 tertiary centers
JA Kari, MA Shalaby, FA Qari, AS Albanna… - Saudi Medical …, 2022 - ncbi.nlm.nih.gov
Objectives: To study childhood nephrolithiasis and nephrocalcinosis caused by metabolic
disorders, distal renal tubular acidosis (dRTA), and familial hypomagnesemia, hypercalciuria, …
disorders, distal renal tubular acidosis (dRTA), and familial hypomagnesemia, hypercalciuria, …
[HTML][HTML] Coronavirus disease in children: a multicentre study from the Kingdom of Saudi Arabia
JA Kari, MA Shalaby, AS Albanna, TS Alahmadi… - Journal of infection and …, 2021 - Elsevier
Background The COVID-19 global pandemic caused by severe acute respiratory syndrome
coronavirus 2 infection, warranted attention for whether it has unique manifestations in …
coronavirus 2 infection, warranted attention for whether it has unique manifestations in …
[PDF][PDF] The impact of unsupervised and unconsented switch of inhalers in patients with controlled asthma–A targeted literature review
AS Albanna, M Alhajji, W Alsowayan… - Annals of Thoracic …, 2023 - journals.lww.com
Inhaler combination formulations consisting of an inhaled corticosteroid (ICS)(fluticasone
propionate) and a long-acting β2 agonist (salmeterol xinafoate) are indicated as maintenance …
propionate) and a long-acting β2 agonist (salmeterol xinafoate) are indicated as maintenance …
The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis
…, AS Albanna, NN Al Shirawi, S Wali… - Annals of Thoracic …, 2017 - journals.lww.com
This is the first guideline developed by the Saudi Thoracic Society for the diagnosis and
management of noncystic fibrosis bronchiectasis. Local experts including pulmonologists, …
management of noncystic fibrosis bronchiectasis. Local experts including pulmonologists, …